Certara, Inc. (NASDAQ:CERT) Receives Average Rating of “Hold” from Analysts

Shares of Certara, Inc. (NASDAQ:CERT) have received a consensus rating of “Hold” from the eleven research firms that are currently covering the stock, MarketBeat reports. Seven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $20.06.

A number of equities research analysts recently commented on CERT shares. Barclays raised their price objective on shares of Certara from $16.00 to $18.00 and gave the stock an “equal weight” rating in a report on Thursday, January 25th. Jefferies Financial Group raised their target price on shares of Certara from $14.00 to $15.50 and gave the company a “hold” rating in a research report on Friday, March 1st. Leerink Partnrs reaffirmed a “market perform” rating on shares of Certara in a research report on Monday, February 26th. KeyCorp raised shares of Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 target price for the company in a research report on Wednesday, April 10th. Finally, JMP Securities started coverage on shares of Certara in a research report on Thursday, April 4th. They issued a “market perform” rating for the company.

Insider Activity

In related news, insider Patrick F. Smith sold 14,427 shares of Certara stock in a transaction dated Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total transaction of $243,094.95. Following the completion of the sale, the insider now owns 50,091 shares of the company’s stock, valued at approximately $844,033.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, SVP Richard M. Traynor sold 3,000 shares of Certara stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $18.00, for a total transaction of $54,000.00. Following the completion of the sale, the senior vice president now owns 173,524 shares of the company’s stock, valued at approximately $3,123,432. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Patrick F. Smith sold 14,427 shares of Certara stock in a transaction dated Tuesday, April 2nd. The stock was sold at an average price of $16.85, for a total transaction of $243,094.95. Following the sale, the insider now directly owns 50,091 shares of the company’s stock, valued at approximately $844,033.35. The disclosure for this sale can be found here. Insiders sold a total of 23,427 shares of company stock valued at $405,095 in the last quarter. Company insiders own 2.39% of the company’s stock.

Institutional Trading of Certara

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Mubadala Investment Co PJSC bought a new stake in shares of Certara during the 4th quarter worth about $169,135,000. William Blair Investment Management LLC raised its stake in Certara by 1.1% in the 3rd quarter. William Blair Investment Management LLC now owns 7,150,914 shares of the company’s stock worth $103,974,000 after purchasing an additional 77,805 shares in the last quarter. Wasatch Advisors LP raised its stake in Certara by 23.4% in the 1st quarter. Wasatch Advisors LP now owns 4,924,845 shares of the company’s stock worth $88,056,000 after purchasing an additional 932,598 shares in the last quarter. Clearbridge Investments LLC raised its stake in Certara by 0.3% in the 4th quarter. Clearbridge Investments LLC now owns 4,140,349 shares of the company’s stock worth $72,829,000 after purchasing an additional 10,429 shares in the last quarter. Finally, Geneva Capital Management LLC raised its stake in Certara by 29.0% in the 4th quarter. Geneva Capital Management LLC now owns 3,824,850 shares of the company’s stock worth $67,279,000 after purchasing an additional 860,763 shares in the last quarter. Institutional investors own 73.96% of the company’s stock.

Certara Trading Up 1.1 %

CERT opened at $17.30 on Thursday. The firm’s fifty day moving average is $17.66 and its two-hundred day moving average is $16.31. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.62 and a current ratio of 2.62. The firm has a market cap of $2.77 billion, a PE ratio of -49.43, a price-to-earnings-growth ratio of 1.76 and a beta of 1.63. Certara has a twelve month low of $11.81 and a twelve month high of $24.61.

Certara (NASDAQ:CERT) last issued its quarterly earnings data on Thursday, February 29th. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.04). Certara had a positive return on equity of 4.33% and a negative net margin of 15.62%. The company had revenue of $88.01 million for the quarter, compared to analyst estimates of $86.80 million. Equities research analysts anticipate that Certara will post 0.29 EPS for the current year.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.